3.840USD-1.54%Mkt Cap: 227.85M USDP/E: —Last update: 2026-06-01
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap227.85M USD
Enterprise Value165.35M USD
Revenue (TTM)32.72M USD
Gross Profit33.29M USD
Net Income (TTM)-52.70M USD
Revenue/Share0.6070 USD
Last Price3.840 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees86
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.64
PEG—
EV/EBITDA-3.03
EV/Revenue5.05
P/S7.15
P/B4.16
EPS (TTM)-0.95
EPS (Forward)-1.48
52W Range
2.20051% of range5.424
52W High5.424 USD
52W Low2.200 USD
Profitability
Gross Margin99.43%
Oper. Margin-20069.09%
EBITDA Margin-166.94%
Profit Margin-157.40%
ROE-98.38%
ROA-45.88%
Growth
Revenue Growth-87.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-48.96M USD
CapEx (TTM)489.00K USD
FCF Margin-79.31%
FCF Yield-11.39%
Net Debt-78.55M USD
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity0.30
Current Ratio7.03
Quick Ratio6.90
Book Value/Sh0.9390 USD
Cash/Share1.576 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)12.29 USD
Target Range9.000 USD – 20.00 USD
# Analysts7
Ownership
Shares Out.59.88M
Float33.55M
Insiders26.23%
Institutions41.69%
Short Interest
Short Ratio3.8d
Short % Float2.29%
Short % Out.1.41%
Shares Short842.29K
Short (prev mo.)886.63K
Technical
SMA 504.197 (-8.5%)
SMA 2003.869 (-0.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)233.07K
Avg Vol (10d)272.72K
Technical Indicators
RSI (14)44.7
MACD-0.0546
MACD Signal-0.0615
MACD Hist.+0.0069
BB Upper4.176 USD
BB Middle3.991 USD
BB Lower3.807 USD
BB Width9.23%
ATR (14)0.1997 USD
Vol Ratio (20d)0.53x